Open access peer-reviewed chapter

Diet and Gallstone

Written By

Reginald del Pozo

Submitted: 29 May 2023 Reviewed: 06 June 2023 Published: 06 September 2023

DOI: 10.5772/intechopen.1002044

From the Edited Volume

Gallbladder - Anatomy, Pathogenesis, and Treatment

Ahmed ElGeidie

Chapter metrics overview

96 Chapter Downloads

View Full Metrics

Abstract

Cholesterol gallstone disease is a major health problem in western countries and depends on genetic and enviromental factors. Diet may influence the formation of gallstone either by altering the biliary lipid composition or by modifying gallbladder motility. Numerous investigations have examined the association of diet and cholesterol gallstone in prospective, cross-sectional, and case-control studies and in experimental animal models. However, these findings are controversial, probably because human studies are mainly epidemiological with differences in study designs, dietary exposure assessment, and methods used. In general, a high intake of saturated fats and refined sugars has been shown to increase the risk of forming cholesterol gallstones, while a high intake of monounsaturated fats and fiber may decrease this process. The pathogenic mechanisms behind these alterations are reviewed, and the need for a nutritional intervention based on a diet low in lipids and rich in fibers is highlighted. A better understanding of the role of diet in gallstone formation may provide tools for those patients who have been diagnosed with symptomatic gallstones and may also contribute to the prophylactic and therapeutic strategies for cholelithiasis.

Keywords

  • dietary impact
  • gallbladder disease
  • gallstones
  • nutrition
  • risk factors

1. Introduction

Cholesterol gallstone disease is a very common pathology in western populations, with a high global prevalence of approximately 10–20%. The etiology of this pathology is considered multifactorial depending on the interaction of numerous complex factors: obesity, dyslipidemia, insulin resistance, high consumption of refined carbohydrates and cholesterol, age, female sex hormones, ethnicity, and sedentary lifestyles [1, 2, 3]. Pathological conditions result from a rapid and large mobilization of body cholesterol to the liver and then to the bile. This situation may cause biliary cholesterol supersaturation, increased cholesterol crystallization, and gallbaldder stasis [4]. The relationship between the secretion of bile acids and either phospholipids or free cholesterol represents important ratios of the secreted molecules, usually causing disturbances that result in a lithogenic bile [5]. The main risk factors in the pathogenesis of gallstones are biliary cholesterol hypersaturation, cholesterol crystallization, cholesterol crystal agglomeration and growth, and gallbladder dysmotility [6, 7]. The relationships between bile acid secretion and free cholesterol are highly species-dependent and, within certain species, are easily affected by diet. However, not all species present biliary characteristics required for cholesterol crystallization and stone formation, such as bile stasis, sludge formation, and nucleating factors, after cholesterol supersaturation is reached [8]. The use of animal models is limited because relatively few species always develop gallstones, and unlike humans, they do not spontaneously generate supersaturated bile in the gallbladder [9]. Therefore, there are certain contradictions in clinical and research studies, whose conclusions should be carefully analyzed. Another difficulty inherent in these studies is the impossibility of knowing the onset time of the disease caused by a specific dietary factor, in addition to not knowing the exact dimension of energy intake and the estimation of the dietary constituents effectively ingested [10].

Many epidemiological studies have associated the formation of cholesterol gallstones with other pathologies such as obesity, hyperlipidemia, and type 2 diabetes mellitus [11, 12, 13]. The presence of multiple risk factors in common with other disease makes it possible to associate gallstone disease with other cardiovascular diseases such as atherosclerosis carotid disease and metabolic dysfunction [14]. Although cholesterol gallstones genesis is multifactorial, basic physiological correlates associated with dietary modulation of biliary lipid metabolism are discussed in relation to gallstone disease. Several investigations have reported on the role of specific dietary constituents as a potential risk factor for cholelithiasis. Diet may influence the formation of gallstones either by modifying gallbladder motility or by altering the biliary lipid composition. The importance of diet in the pathogenesis of gallstones has been much debated. Most of these epidemiological investigations correspond to prospective, cross-sectional, or case-control studies. Some studies show specific nutrients that promote and others that, on the contrary, protect the process of gallstone formation [15]. Among the many dietary factors suggested in the literature, we will focus mainly on total energy intake, intake of carbohydrates, proteins, total fats, saturated fats, mono- and polyunsaturated fats, cholesterol, total fiber, and alcohol. Evidence on the relation between diet and gallstone formation, however, is somewhat conflicting.

The aim of this chapter is to present experimental and epidemiological evidence of dietetic factors that may favor the process of cholesterol gallstone formation.

Advertisement

2. Specific role of various dietary components

A number of dietary factors have been involved in the pathogenesis of cholesterol gallstone formation (Figure 1). It has been reported that Western-type diets, hypercaloric, high in fat and refined sugars, and limited intake of fiber, are factors that increase the possibility of gallstone formation. It is relevant to review nutritional factors that impact the relationship between the relative flow of cholesterol through bile lipids, which constitutes a crucial event in the process of the formation of cholesterol gallstones. Consequently, diet appears to alter most of the components secreted into the bile.

Figure 1.

Effects of major dietary factors (promoting-, preventing- and controversial factors) on gallstone formation.

2.1 Obesity and caloric intake

An excess in energy intake has been related to an increased risk of developing cholelithiasis. Obesity represents the greatest risk factor for cholelthiasis, since it exhibits an increase in the bile secretion of cholesterol from the liver, which generates cholesterol supersaturated bile; crystallization of cholesterol monohydrates; and agglomeration and growth until macroscopic gallstones formation [16, 17]. This excess cholesterol is secreted by hepatocytes as a direct result of increased body weight. It has been estimated that each extra kilogram of body fat yields the production of approximately 20 mg of additional cholesterol [12, 18]. A relevant factor in the process of the formation of cholesterol gallstones is the relative mass of free cholesterol in the bile, which is associated with the consumption of an overload of calories in the diet. Probably the link between obesity and gallstones reflects an excessive production of cholesterol or an increase in its efflux, which are greatly increased both in nonobese and obese patients with this disease [19]. It has recently been reported that high concentrations of C-reactive protein (CRP) could be an independent risk factor that could trigger the process of gallstone formation [20]. It is unknown how an increase in CRP increases the risk of gallstones, but it is suggested that the secretion of the proinflammatory cytokine interleukin-6 is stimulated by adipose tissue, promoting systemic inflammation in obesity [21, 22]. Many case-control studies have examined the relationship between energy intake and the prevalence of gallstone disease, but the findings are controversial. A French study showed a high risk of gallstone disease in men consuming a high-calorie diet, greater than 2500 Kcal per day, but not in women [23]. Similarly, a Spanish study showed a higher consumption of total calories and fat in patients with gallstones compared to healthy controls [24]. In addition, a prospective study (88,837 controls and 612 symptomatic gallstones patients) reported a positive correlation between energy intake and cholelithiasis [18]. Also, another Mendelian randomization study in 77,679 individuals revealed that an increased BMI caused a link with a risk of symptomatic stones [25]. The distribution of body fat also affects the risk of gallstone, with prospective cohort studies showing an association between gallstone formation and central adiposity compared to lower extremity adiposity [26]. An increase in BMI with high waist circumference and central adiposity can influence the key steps involved in the cholesterol gallstone pathogenesis, particularly an increase in biliary cholesterol concentrations [27, 28]. In addition, obese people frequently show a greater fasting gallbladder volume and a decrease in postprandial gallbladder emptying, which are factors that promote gallstones formation [29, 30].

Generally, a weight loss reduces the risk of gallstones, but an excessive weight loss (greater than 25% of body weight) or undergoing bariatric surgery increases the risk of triggering gallstones [31, 32, 33]. The administration of ursodeoxycholic acid during loss of weight could prevent the development of lithogenic changes in bile and the formation of gallstones [34, 35, 36, 37]. Treatment with ursodeoxycholic acid should be reserved for the occasional symptomatic patients with small stones presumably formed from cholesterol or proven gallbladder sludge [38]. A retrospective cross-sectional Asian study observed participants younger than 50 years to have a higher risk gallstone if they were obese and showed features of metabolic syndrome [39]. However, other studies have not found a relationship between caloric intake and cholelithiasis [40, 41]. In contrast, an Italian large cross-sectional, ultrasound-based study reported a significant negative association between energy intake and risk of gallstone disease in men [42]. These discrepancies in the results can be explained by differences in the study design and the methods used to determine energy intake and to diagnose gallstone disease.

2.2 Dietary fatty acids

The role of total dietary fat as an etiologic factor for cholelithiasis has been extensively studied but remains unresolved. The overall impact of dietary total fat on bile lipids in humans is controversial, where the degree of fat saturation itself has been examined for its influence on lithogenesis with ambiguous results. It has been suggested that the type of dietary fat habitually consumed can influence bile composition in humans. In gallbladder, this influence was noted in the presence of more concentrated bile in the olive oil group. However, this was not translated into a modification of cholesterol saturation, which is likely due to the fact that cholesterol gallstones were present by the time the dietary intervention started [43]. Some epidemiological studies did not find a significant positive correlation between total fat intake and the risk of gallstone disease [18, 41, 44], but other studies showed that patients with gallstones consume more total fat, preferably saturated fatty acids. A cross-sectional Danish study reported a positive, but nonsignificant, correlation between total fat consumption, mainly saturated fatty acids, and gallstone disease detected by ultrasound [40]. Another study also reported a positive correlation between symptomatic cholelithiasis and saturated fat intake [23]. A high intake of saturated fat has been also documented in patients from Southern Italy with incident gallstones detected by ultrasound, as compared to controls [45]. Another article showed that a high-fat diet in Balb/c mice, composed mainly of saturated fatty acids, significantly increased biliary cholesterol concentration, without modifying biliary phospholipids concentration [46]. This biliary cholesterol saturation caused an increase in cholesterol concentration in vesicular transporters. Furthermore, an increase in the cholesterol/phospholipid ratio of vesicular transporters was observed in the bile of animals treated with a high-fat diet. These cholesterol-rich vesicular transporters can aggregate and fuse, favoring the cholesterol crystals formation.

It has also been found that a diet rich in trans fatty acids could promote the formation of cholesterol gallstones [47]. Otherwise, consumption of cis-unsaturated fats was reported to have a protective effect in a prospective cohort study [48]. The effect of monounsaturated fatty acids (MUFA) is more contradictory. A study in hamsters reported that a diet rich in MUFAs may decrease the risk of gallstone formation, relative to saturated fats [49]. Other studies showed that patients with gallstone disease consumed more total lipids, mainly saturated fatty acids [24, 50]. But other case-control study found a protective effect of MUFAs on gallstone formation [45]. No significant differences in biliary lithogenicity were reported in normal persons consuming two lipid-lowering diets: one rich in polyunsaturated fatty acids (PUFAs) and the other rich in oleic acid [51].

It was found that a medical combination of ω-3 PUFAs (EPA and DHA) originating from fish oil had a preventive effect against cholesterol gallstone formation in C57BL/6 J mice [52]. Dietary fish oil supplementation decreases hypertriglyceridemia and reduces cholesterol crystal nucleation along with decreased gallstone formation in prairie dogs [53, 54]. In another study, it was found that the administration of a fish oil diet rich in n-3 PUFA to patients with gallstones decreased biliary cholesterol saturation, although without altering cholesterol crystallization time [55]. Dietary n-3 PUFA supplementation was also shown to have a beneficial effect on bile lithogenicity and bile composition in obese women during weight los [56]. These results suggest that n-3 PUFAs supplementation of obese woman on weight reduction treatment maintains the cholesterol saturation index and cholesterol nucleation time, which might prevent the formation of cholesterol gallstones. Various mechanisms may explain the inhibitory effect of fish oil on gallstone formation: reduction in biliary cholesterol saturation, decrease in cholesterol crystallization due to changes in bile phospholipid composition, and reduction in bile protein concentration [55, 57].

Other studies recommended increased nut consumption to decrease the risk of gallstone occurrence [58, 59]. A large prospective cohort study based on the Nurses’ Health Study reported that frequent nut consumption was associated with a lower risk of cholecystectomy in women [60]. Men who consumed nuts five times or more per week appeared to have an approximately 30% lower risk of gallstone disease [59]. Nuts are mostly unsaturated fats [60, 61], a rich source of dietary fiber [60], and have beneficial effects on blood cholesterol and lipoprotein profiles [58].

2.3 Dietary sterols

It is believed that a high cholesterol intake is a predisposing factor to the formation of gallstones. However, epidemiological studies have shown inconclusive results. The experimental consumption of cholesterol by men tends to increase the relative biliary cholesterol concentration and decrease the moles percent of bile acids in both normal subjects [62, 63] and persons with gallstones [62]. Feeding a cholesterol-cholic acid rich diet induces gallstone formation in mice [64]. Feeding excessive cholesterol (>0.85 mg/kcal or 2 g/day human equivalent) is essencially the only way to regularly induce gallstones in most animal model [65]. Under these conditions, bile is typically enriched with cholesterol and reduced in bile acids. A possible mechanism would be that inhibition of hepatic cholesterol synthesis impairs bile acid production in a manner similar to the coordinated inhibition of both cholesterol and bile acid synthesis by lovastatin in humans, while apoE-rich lipoproteins distribute excess absorbed cholesterol directly into the bile [66]. In contrast, other study found no significant increase in biliary cholesterol saturation after 1 month of cholesterol feeding to chickens, rabbits, and rats [67]. Exposure to low dietary cholesterol intake can lead to increased cholesterol synthesis and cholesterol flux into the bile, causing supersaturated bile and thereby increasing the likelihood of forming cholesterol gallstones [10]. These contradictory results may relate to the inclusion of populations from different ethnic groups, with different genetic predisposition and diets, rather than to the effects of cholesterol itself [68].

Plant sterols in diet have been associated with cholesterol gallstone pathogenesis. It was reported that β-sitosterol (a plant sterol present in corn oil, soy, and bran) prevents gallstone formation in mice fed with a lithogenic diet, by decreasing intestinal cholesterol absorption [69]. More recently, a study has demonstrated that plant sterols could inhibit intestinal cholesterol absorption and thus prevent cholesterol gallstone formation [70]. Plant steroids, like diosgenin and other sapogenins, induce massive secretion of cholesterol into rat bile [71]. Legumes that contain significant amounts of sapogenins increase biliary cholesterol saturation and secretion in men and simultaneously decrease serum LDL cholesterol concentration [72, 73]. It is known that the Pima Indians consume large amounts of beans and have one of the highest prevalences of gallstones in the world, a situation that is common with the Chilean Mapuche Indians [10].

2.4 Dietary carbohydrates

Several studies have evaluated the effect of carbohydrates and have revealed that consumption of refined sugars is directly associated with gallbladder disease [4041, 45, 74, 75, 76]. Reducing energy-dense foods, particularly those high in sugar, has shown beneficial effects on both weight and gallstone risk [77]. A prospective study found a significant association between increasing total dietary glycemic load and the subsequent risk of cholecystectomy in women, indicating that both the quality and quantity of carbohydrate intake is important in predicting risk of cholecystectomy [78]. The effect of a high carbohydrate on gallstone risk have been confirmed by a large ultrasonographic study in pregnant women [79]. Women were assessed for dietary habits, and the risk of incident biliary sludge/gallstones during pregnancy was significantly higher among women in the highest quartile of total carbohydrate intake compared with those in the lower quartiles. Another research group concludes that dietary carbohydrates may play a role in cholesterol gallstone formation by altering biliary motility and by enhancing crystal formation. They suggest that a high carbohydrate diet decreases gallbladder volume, shortens cholesterol crystal observation time, and increases crystal mass [80].

Fructose consumption has dramatically increased in past few decades, is mainly consumed through added sugars (sucrose and high fructose corn syrup), and represents up to 10% of total energy in the US and in several European countries [81, 82]. Many studies have assessed the effects of diets providing large amounts of fructose on various species. The general conclusions from these studies are that a high fructose intake almost invariably leads to increased total energy intake, body weight gain, increased plasma triglyceride concentrations, hepatic and extrahepatic insulin resistance, and diabetes mellitus [83, 84, 85]. High intake of fructose (but not sucrose, lactose or galactose) was associated with an increased risk of incident biliary sludge/gallstones, and this association was independent from total carbohydrate intake [79]. The lithogenic effect of fructose appears to depend from several concurrent mechanisms, as induction of insulin resistance, visceral adiposity, metabolic syndrome [86, 87, 88, 89, 90, 91], fatty liver secondary to triglycerides accumulation [92], and gallbladder stasis [80]. The deleterious effects of excess fructose intake can produce gastrointestinal symptoms due to intolerance and intestinal fermentation by resident intestinal microbiota [93] and can affect several liver metabolic pathways (gluconeogenesis, glycerol synthesis, and de novo lipogenesis) [27]. However, other investigations concluded that there is no clear or convincing evidence that any dietary or added sugar has a unique or detrimental impact on the development of obesity or diabetes compared to any other source of calories [94, 95]. It has been recently reported that fructose apparently does not alter the gallstone formation process in Balb/c mice. Changes in plasma, liver, and bile lipids were only observed at very high fructose concentrations diets [96]. The discrepancies in the results with dietary fructose can be explained because an inadequate consideration is often given to the dose at which these effects occur [97] and also because the metabolic effects of fructose differ between individuals based on their genetic background, suggesting heterogeneity in metabolic responses to dietary fructose in humans [98].

2.5 Dietary protein

Dietary protein as a risk modulator for gallbladder disease has been explored with mixed results. Many animal studies have shown a reduction in gallstones, reduced biliary cholesterol and lithogenic index level [99, 100, 101, 102, 103], and lower crystallization rates [104] with higher vegetable protein intake compared to animal protein-rich diets. Human feeding studies examining associations between type (vegetable vs. animal) and quantity of protein and gallbladder disease are limited. Epidemiological studies have observed that people consuming vegetarian diets have a lower incidence of gallbladder disease [105, 106, 107], but specific aspects of the vegetarian diet were not fully elucidated. The studies that probe for associated risks between protein intake and gallbladder disease are conflicting. In the prospective Nurses’ Health Study, women with increased vegetable protein consumption had reduced risk of developing symptomatic gallstones [108] and lower risk for cholecystectomy [109], but two case-control studies [45, 106] and one other prospective cohort study [42] found no association between gallbladder disease and protein intake. A more recent study has measured the associations between gallbladder disease and protein intake patterns, separated by quantity and type (vegetable vs. animal), among postmenopausal women [110]. They concluded that vegetable protein intake is inversely associated with gallbladder disease risk in postmenopausal women. In addition to weight management, healthcare providers could emphasize vegetable protein as an additional dietary modality to promote lower risk for gallbladder disease. In general, the results suggest that the intake of origin and composition of dietary proteins might be more important than total protein intake in gallstone disease risk.

2.6 Dietary fiber

Dietary fiber includes a wide array of complex substances commonly divided into soluble and insoluble components. Some observational studies have illustrated an inverse relationship between dietary fiber intake and the prevalence of gallstones [111, 112]. Another study investigating the effect of diet as a risk factor for cholesterol gallstone disease implicated that lower dietary fiber and higher refined sugar intake were associated with propensity of gallstone formation [10]. Another study shows a protective effect of dietary soluble fiber against cholesterol gallstone formation [113]. In addition, a large number of epidemiological studies have reported an inverse association between insoluble dietary fiber and gallstone disease [40, 41]. In general, by decreasing the intestinal transit time, dietary fibers may reduce the persistence of bacteria located in the colon, which leads to a decrease in the production of secondary bile acids such as deoxycholate, and subsequently, less bile acids are absorbed [114115]. Increasing the absorption of deoxycholate can stimulate biliary cholesterol saturation [16, 116]. Significant reverse associations were observed between odds of gallstone disease and each category of dietary fiber intake. The relationship between dietary fiber intake and the risk of gallstones was more prominent in overweight and obese subjects than in subjects with a normal body mass index [117]. It appears that the fiber effect is multifaceted and potentially extremely complex in its influence on lipoproteins, bile acids, bile lipids, and intestinal sterols, including metabolism by the large bowel flora; therefore, an independent effect of fiber on gallbladder disease needs to be carefully analyzed.

Healthy nutrition recommends eating foods rich in fiber such as fruits and vegetables (FVs). Many constituents of fruits and vegetables may reduce the risk for gallstones, but prospective data relating fruit and vegetable intake to gallstone disease are sparse. An identification of the relationship between vegetables and fruits consumption and gallstone disease may provide the opportunity to reduce occurrence of gallstone disease. Higher consumption of fruit and vegetables is recommended as part of a healthy diet, which might be protective against gallstone disease [118, 119]. However, no unequivocal correlation of FVs consumption with the risk of developing gallstones has been identified. The protective role of FVs consumption on decreasing gallstone risk has been reported in several studies, [110, 120, 121, 122, 123], whereas other studies could not confirm an association [124, 125, 126, 127]. In addition, FVs consumption has been revealed to be negatively correlated with gallstone risk in other researches [125, 128]. Moreover, a linear dose-response correlation indicated that gallstone risk was reduced by 3 and 4% for every 200 g per day increment in FVs consumption, respectively [129]. This inverse association can be explained because a higher FVs consumption increases dietary fiber, which shortens the intestinal transit [114], and dietary fiber has been inversely related to gallstone disease risk [130]. Experimental researches indicated that dietary fiber might decrease both total and LDL cholesterol by increasing bile acid excretion and decreasing hepatic synthesis of cholesterol [131]. In addition, higher FVs consumption possibly reduces fat intake [114]. A recent systematic review and meta-analysis has supported the thesis of a high consumption of FVs as a healthy diet and its recommendation for people to decrease the risk of symptomatic gallstone disease requiring cholecystectomy [129].

2.7 Vitamins and minerals intake

Clinical and experimental data in guinea pigs reported in the 1970s suggested a potential protective effect of vitamin C on the formation of gallstones [132, 133]. Furthermore, animal experiments have shown that animals deficient in vitamin C more frequently develop gallstones [134, 135]. An increased development of gallstones in subjects with vitamin C deficiency might also exist in humans [136]. While a report showed that short-term subclinical vitamin C deficiency in five healthy volunteers did not increase the lithogenic potential of gallbladder bile as it did in guinea pigs fed a high cholesterol diet, another study described changes in the bile salt composition and biliary phospholipid levels of vitamin C treated cholesterol gallstone patients and also found support for the notion that vitamin C supplementation might influence the conditions of cholesterol gallstone formation in humans [137, 138]. In humans, observational studies have also suggested an inverse association between vitamin C intake and gallstone disease [24, 121, 139, 140]. Another study evaluated the potential association of regular vitamin C supplement use on gallstone prevalence, as assessed by ultrasonography and patient’s history, in a cross-sectional survey of randomly selected subjects from the general population. They concluded that gallstone prevalence was half in subjects with regular intake of vitamin C (powder, tablets or capsules) as compared to those not taking the vitamin [141]. A group of patients with cholelithiasis and elective surgery were treated with vitamin C (2 g per day for 2 weeks) orally for 2 weeks before surgery. Vitamin C supplementation did not change significantly plasma lipids and bile lipid concentrations, but in supplemented patients, significant reductions in biliary vesicular cholesterol content and biliary vesicular cholesterol/phospholipid ratio were observed [142]. Summing up, a vitamin C deficiency appears to promote gallstone formation, whereas a vitamin C supplement prevents lithogenesis. Vitamin C modulates the hepatic and biliary pathways of cholesterol homeostasis by promoting the conversion of cholesterol into bile acids through liver 7α-hydroxylation, by prolongation of the crystallization time [138] due to qualitative changes in the bile acid composition, and by a decrease in the cholesterol content of the thermodynamically unstable vesicles in the bile [142].

There are few studies on other vitamins and minerals. Calcium intake was inversely associated with gallstone incidence [24, 41, 143], but others found no association [44, 144]. Calcium may alter the composition of bile by preventing the reabsorption of secondary bile acids in the colon, thus reducing the deoxycholate and cholesterol content of the bile [145].

Animals receiving an iron-deficient diet were more likely to have cholesterol crystals in their bile than those on the control diet, suggesting that a low-iron diet may increase the risk of forming gallstones [146]. Some studies have reported associations with vitamin E [144], folate, or magnesium deficiency [147], but they are few and inconclusive [24, 144].

2.8 Coffee consumption

Metabolic studies suggest that coffee intake may influence gallstone formation [148, 149, 150, 151, 152, 153]. Many studies indicate a potential protective effect of caffeine on gallstone formation [154, 155, 156, 157, 158, 159]. On the other hand, other studies are not so clear in showing this effect [105, 160, 161], showing contradictory results. The effect is mainly mediated by the decreased hepatic synthesis and secretion of cholesterol [151, 153] and a positive effect on gallbladder motility [148, 150] and intestinal [162]. An inverse association between coffee consumption and risk of cholecystectomy in women who were premenopausal or used hormone replacement therapy but not in other women or in men was observed [163]. This indicates that the observed association between coffee consumption and cholecystectomy depended on the presence of female sex hormones. In view of the heterogeneous findings from other studies, the true nature of this association is yet to be established.

2.9 Alcohol consumption

Notwithstanding that alcohol consumption is a known risk factor for many chronic diseases and malignancies [164, 165, 166], there have been many clinical epidemiological studies regarding the negative correlation between alcohol consumption and gallstone disease risk. There were two published meta-analyses regarding the correlation between alcohol consumption and gallstone development risk [167, 168]. One meta-analysis found no significant correlation between alcohol consumption and incidental gallstone risks [167]. Another meta-analysis showed a statistically significant, inverse relationship between the highest and lowest consumption categories (RR, 0.62; 95% CI, 0.49 to 0.78), whose pooled risk reduction was larger than that of the overall drinking data relative to nondrinking or to the lowest category in this meta-analysis [168]. Other study discovered a trend of linear decline in gallstone disease risk according to an increase in alcohol consumption and a weakened linear trend between 28 and 40 g/day compared to that of under 28 g/day in the overall and case-control studies but not in the cohort studies [169]. Later studies demonstrated an inverse relation between consumption of different alcoholic beverages (wine, beer, liquors) and the risk of cholecystectomy [170], while a protective effect of small doses of alcohol (particularly in men) was documented in the cohort from the European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk) [171]. However, the topic is controversial in many respects: not all studies have confirmed the protective effect of alcohol on gallstone disease [105, 172]. Such general pathophysiological effect of alcohol on biliary function needs clinical confirmation. Alcohol inhibits the cholesteryl ester transfer protein (CETP)-mediated conversion of HDL into low-density lipoprotein (LDL)-cholesterol [173]. This step is followed by increased HDL cholesterol concentrations, which are inversely correlated with biliary cholesterol saturation [174, 175]. Small doses of alcohol also stimulate gallbladder contractility through increased cholecystokinin release [176, 177]. In general, the results of the effect of alcohol on gallstone formation are inconsistent, and it appears that the metabolic status of the host may be an important variable.

2.10 Nicotine and lithogenic diet

Some research has shown an influence of smoking on the development of gallstones [178, 179]. On the other hand, several studies suggest that smoking is not a risk factor for gallstones and even has the opposite effect [180, 181]. Compared with nonsmokers, older smokers who smoke for most of their lives have a lower risk of gallstone disease [182]. Megalin and cubilin proteins are expressed in gallbladder epithelial cells but not in hepatocytes. Dysregulation of megalin and cubilin at the mRNA and protein levels has been found in either humans or mice with gallstones [183184]. It was shown that bile acids can regulate the expression of megalin and cubilin, an effect that appeared to be mediated by the bile acid nuclear hormone receptor farnesoid X receptor (FXR) [185]. FXR can regulate the synthesis of bile acids in a tissue-specific manner, regulating bile acid reabsorption, maintaining bile acid cycle homeostasis, and reducing cholesterol and fat production [186]. In animals treated with a lithogenic diet, it was found that nicotine did not prevent cholesterol gallstone formation, but decreased biliary cholesterol secretion, retarding phase transition of cholesterol and that this is likely due to nicotine changing the expression of FXR/megalin pathway [187]. Despite unlikely therapeutic applications, nicotine might have potential beneficial effects for anti-lithogenic activity. However, further assessment of the direct effect of megalin and cubilin regulated by nicotine on gallstone formation is required.

Advertisement

3. Diet after cholecystectomy

Previous studies show that long-term abdominal symptoms are present in up to 40% of patients after laparoscopic cholecystectomy [188, 189, 190], which are summarized as “postcholecystectomy síndrome”. It is thought that the symptoms are not caused by, but are exacerbated by, the cholecystectomy. Symptoms may include upset stomach, nausea, vomiting, gas, bloating, diarrea, or persistent pain in the upper right abdomen. The absence of the gallbladder after a cholecystectomy was reported to cause rapid enterohepatic recycling, an increase in the secretion and a decrease in the reabsorption of bile acid, and a shortened colonic transit time [191, 192]. Some patients who underwent cholecystectomy experienced diarrhea, which could be associated with the malabsorption of bile acid [193]. In addition, patients may experience symptoms of gastritis secondary to duodenogastric reflux of bile acids [191]. These abdominal symptoms suggest a relationship between cholecystectomic symptoms and diet, although the details of this association remain unclear.

There is not a standard guideline for medical nutrition theraphy postcholecystectomy. Many studies have focused on the relationship between a high-fat diet and postcholecystectomic syndromes [194, 195, 196, 197]. A high-fat diet could be associated with postcholecystectomic diarrhea, due to the changes in bile acid metabolism. However, more recent research has not found a significant association between the intake of fat and the risk for postcholecystectomic syndromes [198, 199]. A low-fat diet does not seem to have an influence on the improvement of symptoms after cholecystectomy [199]. Despite this, it is recommended that fat intake should be limited for several months to allow the liver to compensate for the gallbladder’s absence, should be introduced gradually, and excessive amounts at any one meal should be avoided [200]. Eggs could be a source of animal protein and cholesterol, which were also positively associated with the risk of postcholecystectomic syndromes [198]. Intake of protein had been reported to slow gastric emptying in healthy volunteers [201], and dietary cholesterol increased fecal excretion of bile acids in rats [202]. Malabsorption of bile acids has been shown to cause postcholecystectomic diarrhea [193, 203], since the absence of a gallbladder caused more rapid enterohepatic recycling of bile acids, increased bile acid secretion [193], and shortened colonic transit times [192]. The aforementioned studies suggested that excretion and malabsorption of bile acids could be exacerbated by cholesterol intake in patients with cholecystectomies. On the other hand, an increased fiber intake will help normalize bowel movements. It is recommended to increase fiber intake slowly, over several weeks [198, 200]. It has been suggested that adding soluble fiber to the diet will act as a sequestering agent and bind the bile in the stomach between meals to avoid gastritis [204]. In addition, symptomatic patients consumed more bread-based breakfast foods, while asymptomatic patients consumed more rice [198]. Another study found that the risk of nonalcoholic fatty liver disease (NAFLD) was negatively associated with a healthy dietary pattern of consuming whole grains, legumes, vegetables, fish, and fruit and with an erythrocyte level of n-3 polyunsaturated fatty acids rich in fish [205].

Therefore, it is important for patients who have undergone cholecystectomy to maintain a healthy diet that is rich in whole grains, legumes, vegetables, fish, and fruit and low in animal protein, cholesterol, and eggs. Additionally, it is recommended to avoid refined grains, meat, processed meat, and fried foods, which were positively associated with the risk of NAFLD [205]. However, each patient’s dietary needs may vary, and it is recommended to consult with a healthcare professional or a registered dietitian for personalized dietary recommendations.

Advertisement

4. Conclusion

The high prevalence of cholesterol gallstones, the availability of new information about pathogenesis, and the relevant health costs due to the management of cholelithiasis in both children and adults contribute to a growing interest in this disease. Gallstone formation is multifactorial, resulting from an intricate interaction between multiple genetic, environmental, and lifestyle determinants. Cholelithiasis appears as the expression of systemic unbalances that, besides the classic therapeutic approaches to patients with clinical evidence of symptomatic disease or complications (mainly surgery), could be managed with tools oriented to primary prevention such as diet and lifestyle changes, which could imply a reduction in both prevalence and health costs. A major intervention in the general population should include lifestyle change, including dietary models able to possibly reduce the risk of gallstones mainly acting on lipid metabolism and metabolic pathways leading to gallstone formation. The risk of developing gallstones appears to increase with some dietary factors such as an increased of energy intake, low dietary fiber content, high refined sugar intake, and high fructose and fat intake and, on the other hand, to decrease with others like olive oil consumption (ω-3 fatty acids), high intake of monounsaturated fats and fiber, vegetables and fruits, vitamin C supplementation, nut consumption, dietary magnesium-calcium-iron supplementation, and moderate alcohol consumption (Figure 1) [1, 13, 15].

The complex and variable interactions of such pathogenic factors contributing to cholesterol cholelithiasis require a comprehensive discussion to correctly address the management of the disease. Studies that defined specific population with the consideration of multidimensional factors should be employed during the screening of populations with cholelithiasis. A better understanding of the role of diet in the formation of gallstones can provide resources and education to those patients who have been diagnosed with symptomatic gallstones and can also aid in the prevention and therapy of cholelithiasis.

Advertisement

Acknowledgments

  • This work was partially supported by DINREG 12/2017 project (Direccion Investigacion, Universidad Catolica de la Santisima Concepcion).

  • The graphic work of the Unit of Graphic Support (UAD) of Medicine Faculty, Universidad Catolica de la Santisima Concepcion, is appreciated.

References

  1. 1. Pak M, Lindseth G. Risk factors for cholelithiasis. Gastroenterology Nursing. 2016;39(4):297-309. DOI: 10.1097/SGA.0000000000000235
  2. 2. Lammert F, Sauerbruch T. Mechanisms of disease: The genetic epidemiology of gallbladder stones. Nature Clinical Practice. Gastroenterology & Hepatology. 2005;2(9):423-433
  3. 3. Dowling RH. Review: Pathogenesis of gallstones. Alimentary Pharmacology & Therapeutics. 2000;14(Suppl 2):39-47. DOI: 10.1046/j.1365-2036.2000.014s2039.x
  4. 4. Lammert F, Gurusamy Ko CW, Miquel JF, Mendez-Sanchez N, Portincasa P, van Erpecum KJ, et al. Gallstones. Nature Reviews. Disease Primers. 2016;2:16024. DOI: 10.1038/nrdp.2016.24
  5. 5. Hofmann AF. Bile acid secretion, bile flow and biliary lipid secretion in humans. Hepatology. 1990;12(3 Pt 2):17S-22S discussion 22S-25S
  6. 6. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230-239. DOI: 10.1016/S0140-6736(06)69044-2
  7. 7. Méndez-Sánchez N, Cárdenas-Vásquez R, Ponciano-Rodríguez G, et al. Pathophysiology of cholesterol gallstone disease. Archives of Medical Research. 1996;27(4):433-441
  8. 8. Holzbach RT. Current concepts of cholesterol transport and crystal formation in human bile. Hepatology. 1990;12(3 Pt 2):26S-31S discussion 31S-32S
  9. 9. Lagarriga Attias J, Mendez-Sanchez N, Chiprut Obadia RS, Cohen YJ. Experimental cholelithiasis in animals. Revista de Gastroenterología de México. 1978;43(3):147-161
  10. 10. Cuevas A, Miquel JF, Reyes MS, Zanlungo S, Nervi F. Diet as a risk factor for cholesterol gallstone disease. Journal of the American College of Nutrition. 2004;23(3):187-196. DOI: 10.1080/07315724.2004.10719360
  11. 11. Paumgartner G, Sauerbruch T. Gallstones: Pathogenesis. Lancet. 1991;338(8775):1117-1121. DOI: 10.1016/0140-6736(91)91972-w
  12. 12. Stokes CS, Lammert F. Excess body weight and gallstone disease. Visceral Medicine. 2021;37(4):254-260. DOI: 10.1159/000516418
  13. 13. Di Ciaula A, Portincasa P. Recent advances in understanding and managing cholesterol gallstones. F1000Res. 2018;7:F1000. DOI: 10.12688/f1000research.15505.1 eCollection 2018
  14. 14. Mendez-Sanchez N, Bahena-Aponte J, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez G, et al. Strong association between gallstones and cardiovascular disease. The American Journal of Gastroenterology. 2005;100(4):827-830. DOI: 10.1111/j.1572-0241.2005.41214.x
  15. 15. Di Ciaula A, Garruti G, Frühbeck G, De Angelis M, de Bari O, Wang D, et al. The role of diet in the pathogenesis of cholesterol gallstones. Current Medicinal Chemistry. 2019;26(19):3620-3638. DOI: 10.2174/09298673246661 70530080636
  16. 16. Hayes KC, Livingston A, Trautwein EA. Dietary impact on biliary lipids and gallstones. Annual Review of Nutrition. 1992;12:299-326. DOI: 10.1146/annurev.nu.12.070192.001503
  17. 17. Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones: A parsimonious hypothesis. European Journal of Clinical Investigation. 1996;26(5):343-352. DOI: 10.1046/j.1365-2362.1996.148287.x
  18. 18. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. The New England Journal of Medicine. 1989;321(9):563-569. DOI: 10.1056/NEJM198908313210902
  19. 19. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man. The New England Journal of Medicine. 1978;299(22):1221-1227. DOI: 10.1056/NEJM197811302992205
  20. 20. Liu T, Siyin ST, Tao N, Duan N, Xu G, Li W, et al. Relationship between high-sensitivity C reactive protein and the risk of gallstone disease: Results from the Kailuan cohort study. BMJ Open. 2020;10(9):e035880. DOI: 10.1136/bmjopen-2019-035880
  21. 21. Kwaifa IK, Bahari H, Yong YK, Noor SM. Endothelial dysfunction in obesity-induced inflammation: Molecular mechanisms and clinical implications. Biomolecules. 2020;10(2):291. DOI: 10.3390/biom10020291
  22. 22. Cozma A, Orasan O, Sampelean D, Fodor A, Vlad C, Negrean V, et al. Endothelial dysfunction in metabolic sindrome. Romanian Journal of Internal Medicine. 2009;47(2):133-140
  23. 23. Caroli-Bosc FX, Deveau C, Peten EP, Delabre P, Zanaldi H, Hebuterne X, et al. Cholelithiasis and dietary risk factors: An epidemiologic investigation in Vidauban, Southeast France. General Practitioner’s group of Vidauban. Digestive Diseases and Sciences. 1998;43(9):2131-2137. DOI: 10.1023/a:1018879819301
  24. 24. Ortega RM, Fernandez-Azuela M, Encinas Sotillos A, Andres P, Lopez-Sobaler AM. Differences in diet and food habits between patients with gallstones and controls. Journal of the American College of Nutrition. 1997;16(1):88-95. DOI: 10.1080/07315724.1997.10718655
  25. 25. Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: A Mendelian randomization study. Hepatology. 2013;58(6):2133-2141. DOI: 10.1002/hep.26563
  26. 26. Haffner SM, Diehl AK, Stern MP, Hazuda HP. Central adiposity and gallbladder disease in Mexican Americans. American Journal of Epidemiology. 1989;129(3):587-595. DOI: 10.1093/oxfordjournals.aje.a115171
  27. 27. Wang DQH, Neuschwander-Tetri BA, Portincasa P. The Biliary System. 1st ed. Princeton, New Jersey: Morgan & Claypool Life Sciences; 2012. pp. 1-146
  28. 28. Stahlberg D, Rudling M, Angelin B, Bjorkhem I, Forsell P, Nilsell K, et al. Hepatic cholesterol metabolism in human obesity. Hepatology. 1997;25(6):1447-1450. DOI: 10.1002/hep.510250623
  29. 29. Di Ciaula A, Wang DQ , Portincasa P. Gallbladder and gastric motility in obese newborns, preadolescents and adults. Journal of Gastroenterology and Hepatology. 2012;27(8):1298-1305. DOI: 10.1111/j.1440-1746.2012.07149.x
  30. 30. Mathus-Vliegen EM, Van Ierland-Van Leeuwen ML, Terpstra A. Determinants of gallbladder kinetics in obesity. Digestive Diseases and Sciences 2004;49(1):9-16. DOI: 10.1023/b:ddas.0000011595.39555.c0
  31. 31. Tsai AG, Wadden TA. Systematic review: An evaluation of major comercial weight loss programs in the United States. Annals of Internal Medicine. 2005;142(1):56-66. DOI: 10.7326/0003-4819-142-1-200501040-00012
  32. 32. Johansson K, Sundstrom J, Marcus C, Hemmingsson E, Neonius M. Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a comercial weight los programm: 1-year matched cohort study. International Journal of Obesity. 2014;38(2):279-284. DOI: 10.1038/ijo.2013.83
  33. 33. Li VK, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Martinez-Duartz P. Predictors of gallstone formation after bariatric surgery: A multivariante analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surgical Endoscopy. 2009;23(7):1640-1644. DOI: 10.1007/s00464-008-0204-6
  34. 34. Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, et al. Effects of Ursodeoxycholic acid and aspirin on the formation of Lithogenic bile and gallstones during loss of weight. The New England Journal of Medicine. 1988;319:1567-1572. DOI: 10.1056/NEJM198812153192403
  35. 35. Jang S, Fang S, Kim KP, Ko Y, Kim H, Oh J, et al. Combination treatment with n-3 polyunsaturated fatty acids and ursodeoxycholic acid dissolves cholesterol gallstones in mice. Scientific Reports. 2019;9(1):12740. DOI: 10.1038/s41598-019-49095-z
  36. 36. Jüngst D, Brenner G, Pratschke E, Paumgartner G. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones. Journal of Hepatology. 1989;8(1):1-6. DOI: 10.1016/0168-8278(89)90154-2
  37. 37. Jüngst C, Sreejayan N, Zündt B, Müller I, Spelsberg FW, Hüttl TP, et al. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones. European Journal of Clinical Investigation. 2008;38(9):634-639. DOI: 10.1111/j.1365-2362.2008.01995.x
  38. 38. Gutt C, Schläfer S, Lammert F. The treatment of gallstone disease. Deutsches Ärzteblatt International. 2020;117(9):148-158. DOI: 10.3238/arztebl.2020.0148
  39. 39. Su PY, Hsu YC, Cheng YF, Kor CT, Su WW. Strong association between metabolically abnormal obesity and gallstone disease in adults under 50 years. BMC Gastroenterology. 2019;19(1):117. DOI: 10.1186/s12876-019-1032-y
  40. 40. Jorgensen T, Jorgensen LM. Gallstones and diet in a Danish population. Scandinavian Journal of Gastroenterology. 1989;24(7):821-826. DOI: 10.3109/00365528909089221
  41. 41. Moerman CJ, Smeets FW, Kromhout D. Dietary risk factors for clinically diagnosed gallstones in middle-aged men. A 25-year follow-up study. Annals of Epidemiology. 1994;4(3):248-254. DOI: 10.1016/1047-2797(94)90104-x
  42. 42. Attili AF, Scafato E, Marchioli R, Marfisi RM, Festi D. Diet and gallstones in Italy: Cross-sectional MICOL results. Hepatology. 1998;27(6):1492-1498. DOI: 10.1002/hep.510270605
  43. 43. Yago MD, Gonzalez V, Serrano P, et al. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease. Nutrition. 2005;21(3):339-347. DOI: 10.1016/j.nut.2004.06.028
  44. 44. Sichierei R, Everhart JE, Roth H. A propspective study of hospitalization with gallstone disease among women: Role of dietary factors, fasting period, and dieting. American Journal of Public Health. 1991;81(7):880-884. DOI: 10.2105/ajph.81.7.880
  45. 45. Misciagna G, Centonze S, Leoci C, Guerra V, Cisternino AM, Ceo R, et al. Diet, physical activity, and gallstones: A population-based, case-control study in southern Italy. The American Journal of Clinical Nutrition. 1999;69(1):120-126. DOI: 10.1093/ajcn/69.1.120
  46. 46. del Pozo R, Mardones L, Villagran M, Muñoz K, Roa S, Rozas F, et al. Effect of a high-fat diet on cholesterol gallstone formation. Revista Médica de Chile. 2017;145(9):1099-1105
  47. 47. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-term intake of trans-fatty acids and risk of gallstone disease in men. Archives of Internal Medicine. 2005;165(9):1011-1015. DOI: 10.1001/archinte.165.9.1011
  48. 48. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: A prospective cohort study. Annals of Internal Medicine. 2004;141(7):514-522. DOI: 10.7326/0003-4819-141-7-200410050-00007
  49. 49. Jonnalagadda SS, Trautwein EA, Hayes KC. Dietary fats rich in saturated fatty acids (12:0, 14:0, and 16:0) enhance gallstone formation relative to monounsaturated fat (18:1) in cholesterol-fed hamsters. Lipids. 1995;30(5):415-424. DOI: 10.1007/BF02536299
  50. 50. Tandon RK, Saraya A, Paul S, Kapur BM. Dietary habits of gallstone patients in northern India. Journal of Clinical Gastroenterology. 1996;22(1):23-27. DOI: 10.1097/00004836-199601000-00007
  51. 51. Schlierf G, Nikolaus T, Stichl A, et al. The effect of lipid level lowering diets on bile lipids and plasma lipoproteins in normal persons. Schweizerische Medizinische Wochenschrift. 1979;109(45):1743-1747
  52. 52. Soo-Min C, Jin-A P, Dong-Soon K, Zhang D, Yi H, Hee-Jung C, et al. Effect of eicosapentaenoic acid on cholesterol gallstone formation in C57BL/6J mice. Molecular Medicine Reports. 2015;11(1):362-366. DOI: 10.3892/mmr.2014.2687
  53. 53. Jonkers IJ, Smelt AH, Ledeboer M, Hollum ME, Biemond I, Kuipers F, et al. Gallbladder dysmotility: A risk factor for gallstone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut. 2003;52(1):109-115. DOI: 10.1136/gut.52.1.109
  54. 54. Magnuson TH, Lillemoe KD, High RC, Pitt HA. Dietary fish oil inhibits cholesterol monohydrate crystal nucleation and gallstone formation in the prairie dog. Surgery. 1995;118(3):517-523. DOI: 10.1016/s0039-6060(05)80368-x
  55. 55. Berr F, Holl J, Jüngst D, Fischer S, Richter WO, Seifferth B, et al. Dietary n-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease. Hepatology. 1992;16(4):960-967. DOI: 10.1002/hep.1840160418
  56. 56. Mendez-Sanchez N, Gonzalez V, Aguayo P, Sanchez JM, Tanimoto MA, Elizondo J, et al. Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight. The Journal of Nutrition. 2001;131(9):2300-2303. DOI: 10.1093/jn/131.9.2300
  57. 57. Booker ML, Scott TE, LaMorte WW. Effects of dietary fish oil on biliary phospholipids and prostaglandin synthesis in the cholesterol-fed prairie dog. Lipids. 1990;25(1):27-32. DOI: 10.1007/BF02562424
  58. 58. Almario RU, Vonghavaravat V, Wong R, Kasim-Karakas SE. Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. American Journal of Clinical Nutrition. 2001;74(1):72-79. DOI: 10.1093/ajcn/74.1.72
  59. 59. Tsai CJ, Leitzmann MF, Hu FB, Willett WC, Giovannucci EL. A prospective cohort study of nut consumption and the risk of gallstone disease. American Journal of Epidemiology. 2004;160(1):961-968. DOI: 10.1093/aje/kwh302
  60. 60. Kris-Etherton PM, Zhao G, Binkoski AE, Coval SE, Etherton TD. The effects of nuts on coronary heart disease risk. Nutrition Reviews. 2001;59:103-111. DOI: 10.1111/j.1753-4887.2001.tb06996.x
  61. 61. Rajaram S, Burke K, Connell B, Myint T, Sabate J. A monounsaturated fatty acid-rich pecan-enriched diet favorably laters the serum lipid profile of healthy men and women. Journal of Nutrition. 2001;131:2275-2279. DOI: 10.1093/jn/131.9.2275
  62. 62. Lee DW, Gilmore CJ, Bonorris G, Cohen H, Marks JW, et al. Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects and persons with gallstones. The American Journal of Clinical Nutrition. 1985;42(3):414-420. DOI: 10.1093/ajcn/42.3.414
  63. 63. DenBesten L, Connor WE, Bell S. The effect of dietary cholesterol on the composition of human bile. Surgery. 1973;73(2):266-273
  64. 64. Tepperman J, Caldwell FT, Tepperman HM. Induction of gallstones in mice by feeding a cholesterol-cholic acid containing diet. The American Journal of Physiology. 1964;206:628-634. DOI: 10.1152/ajplegacy.1964.206.3.628
  65. 65. Hayes KC, Khosla P, Pronczuk A. Diet-induced type IV-like hyperlipidemia and increased body weight are associated with cholesterol gallstones in hamsters. Lipids. 1991;26(9):729-735. DOI: 10.1007/BF02535622
  66. 66. Mitchell JC, Loan GM, Stone BG, Duane WC. Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans. Journal of Lipid Research. 1991;32(1):71-78
  67. 67. Ho KJ. Comparative studies on the effect of cholesterol feeding on biliary composition. The American Journal of Clinical Nutrition. 1976;29(7):698-704. DOI: 10.1093/ajcn/29.7.698
  68. 68. Méndez-Sánchez N, Zamora-Valdés D, Chávez-Tapia NC, Uribe M. Role of diet in cholesterol gallstone formation. Clinica Chimica Acta. 2007;376(1-2):1-8. DOI: 10.1016/j.cca.2006.08.036
  69. 69. Goswami SK, Frey CF. Effect of beta-sitosterol on cholesterol-cholic acid-induced gallstone formation in mice. The American Journal of Gastroenterology. 1976;65(4):305-310
  70. 70. Shen W, Wang Y, Shao W, Wang Q , Jiang Z, Hu H. Dietary plant sterols prevented cholesterol gallstone formation in mice. Food & Function. 2021;12(23):11829-11837. DOI: 10.1039/d1fo02695j
  71. 71. Ulloa N, Nervi F. Mechanism and kinetic characteristics of the uncoupling by plant steroids of biliary cholesterol from bile salt output. Biochimica et Biophysica Acta. 1985;837(2):181-189. DOI: 10.1016/0005-2760(85)90241-3
  72. 72. Nervi F, Covarrubias C, Bravo P, Velasco N, Ulloa N, Cruz F, et al. Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Gastroenterology. 1989;96(3):825-830
  73. 73. Duane WC. Effects of legume consumption on serum cholesterol, biliary lipids, and sterol metabolism in humans. Journal of Lipid Research. 1997;38(6):1120-1128
  74. 74. Scragg RK, McMichael AJ, Baghurst PA. Diet, alcohol, and relative weight in gallstone disease: A case-control study. British Medical Journal (Clinical Research Ed.). 1984;288(6424):1113-1119. DOI: 10.1136/bmj.288.6424.1113
  75. 75. Diehl AK, Haffner SM, Knapp JA, Hazuda HP, Stern MP. Dietary intake and the prevalence of gallbladder disease in Mexican Americans. Gastroenterology. 1989;97(6):1527-1533. DOI: 10.1016/0016-5085(89)90399-5
  76. 76. Thornton JR, Emmet P, Heaton KW. Diet and gallstones: Effect of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism. Gut. 1983;24(1):2-6. DOI: 10.1136/gut.24.1.2
  77. 77. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Interdisziplinäre Leitlinie der Qualität S3 zur Prävention und Therapie der Adipositas-Gesellschaft. Martinsried: AWMF; 2014
  78. 78. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Glycemic load, glycemic index, and carbohydrate intake in relation to risk of cholecystectomy in women. Gastroenterology. 2005;129(1):105-112. DOI: 10.1053/j.gastro.2005.05.016
  79. 79. Wong AC, Ko CW. Carbohydrate intake as a risk factor for biliary sludge and stones during pregnancy. Journal of Clinical Gastroenterology. 2013;47(8):700-705. DOI: 10.1097/MCG.0b013e318286fdb0
  80. 80. Mathur A, Megan M, Al-Azzawi HH, Lu D, Swartz-Basile DA, Nakeeb A, et al. High dietary carbohydrates decrease gallbladder volume and enhance cholesterol crystal formation. Surgery. 2007;141(5):654-659. DOI: 10.1016/j.surg.2006.11.008
  81. 81. Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM. Dietary fructose consumption among US children and adults: The third National Health and nutrition examination survey. Medscape Journal of Medicine. 2008;10(7):160
  82. 82. Softic S, Cohen DE, Kahn CR. Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Digestive Diseases and Sciences. 2016;61(5):1282-1293. DOI: 10.1007/s10620-016-4054-0
  83. 83. Bizeau ME, Pagliassotti MJ. Hepatic adaptations to sucrose and fructose. Metabolism. 2005;54(9):1189-1201. DOI: 10.1016/j.metabol.2005.04.004
  84. 84. Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiological Reviews. 2010;90(1):23-46. DOI: 10.1152/physrev.00019.2009
  85. 85. Jung S, Bae H, Song WS, Jang C. Dietary fructose and fructose-induced pathologies. Annual Review of Nutrition. 2022;42:45-66. DOI: 10.1146/annurev-nutr-062220-025831
  86. 86. Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S, Tappy L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes. 2005;54(7):1907-1913. DOI: 10.2337/diabetes.54.7.1907
  87. 87. Dirlewanger M, Schneiter P, Jequier E, Tappy L. Effects of fructose on hepatic glucose metabolism in humans. American Journal of Physiology. Endocrinology and Metabolism. 2000;279:E907-E911
  88. 88. Biddinger SB, Haas JT, Yu BB, Bezy O, Jing E, Zhang W, et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nature Medicine. 2008;14(7):778-782. DOI: 10.1038/nm1785
  89. 89. Tappy L, Le KA, Tran C, Paquot N. Fructose and metabolic diseases: New findings, new questions. Nutrition. 2010;26(11-12):1044-1049. DOI: 10.1016/j.nut.2010.02.014
  90. 90. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2008;295(5):G987-G995. DOI: 10.1152/ajpgi.90272.2008
  91. 91. Stanhope KL, Bremer AA, Medici V, Nakajima K, Ito Y, Nakano T, et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apoliporotein-B in young men and women. The Journal of Clinical Endocrinology and Metabolism. 2011;96(10):E1596-E1605. DOI: 10.1210/jc.2011-1251
  92. 92. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nature Reviews. Gastroenterology & Hepatology. 2010;7(5):251-264. DOI: 10.1038/nrgastro.2010.41
  93. 93. Bonfrate L, Krawczyk M, Lembo A, Grattagliano I, Lammert F, Portincasa P. Effects of dietary education, followed by a tailored fructose-restricted diet in adults with fructose malabsorption. European Journal of Gastroenterology & Hepatology. 2015;27(7):785-796. DOI: 10.1097/MEG.0000000000000374
  94. 94. Kahn R, Sievenpiper JL. Dietary sugar and body weight: Have we reached a crisis in the epidemic of obesity and diabetes?: We have, but the pox on sugar is overwrought and overworked. Diabetes Care. 2014;37(4):957-962. DOI: 10.2337/dc13-2506
  95. 95. Tappy L, Mittendorfer B. Fructose toxicity: Is the science ready for public health actions? Current Opinion in Clinical Nutrition and Metabolic Care. 2012;15(4):357-361. DOI: 10.1097/MCO.0b013e328354727e
  96. 96. del Pozo R, Mardones L, Villagran M, Muñoz K, Troncoso L, Mellado M, et al. Effect of various concentrations of dietary fructose on gallstone formation process in Balb/c mice. Nutricion Hospitalaria. 2023 (in press)
  97. 97. Livesey G, Taylor R. Fructose consumption and consequences for glycation, plasma triglycerides and body weight: Meta-analyses and meta-regression models of intervention studies. The American Journal of Clinical Nutrition. 2008;88(5):1419-1437. DOI: 10.3945/ajcn.2007.25700
  98. 98. Hou R, Panda C, Voruganti VS. Heterogeneity in metabolic responses to dietary fructose. Frontiers in Genetics. 2019;10:945. DOI: 10.3389/fgene.2019.00945
  99. 99. Kritchevsky D, Klurfeld DM. Influence of vegetable protein on gallstone formation in hamsters. The American Journal of Clinical Nutrition. 1979;32:2174-2176. DOI: 10.1093/ajcn/32.11.2174
  100. 100. Kritchevsky D, Klurfeld DM. Gallstone formation in hamsters: Effect of varying animal and vegetable protein levels. The American Journal of Clinical Nutrition. 1983;37(5):802-804. DOI: 10.1093/ajcn/37.5.802
  101. 101. Mahfouz-Cercone S, Johnson JE, Liepa GU. Effect of dietary animal and vegetable protein on gallstone formation and biliary constituents in the hamster. Lipids. 1984;19(1):5-10. DOI: 10.1007/BF02534601
  102. 102. Sullivan MA, Duffy A, Dimarco N, Liepa G. Effects of various dietary animal and vegetable proteins on serum and biliary lipids and on gallstone formation in the hamster. Lipids. 1985;20(1):1-6. DOI: 10.1007/BF02534354
  103. 103. Tomotake H, Yamamoto N, Yanaka N, Ohinata H, Yamazaki R, Kayashita J, et al. High protein buckwheat flour suppresses hypercholesterolemia in rats and gallstone formation in mice by hypercholesterolemic diet and body fat in rats because of its low protein digestibility. Nutrition. 2006;22(2):166-173. DOI: 10.1016/j.nut.2005.01.012
  104. 104. Catala I, Juste C, Boehler N, Ferezou J, Andre M, Riottot M, et al. Cholesterol crystallization in gall-bladder bile of pigs given cholesterol-beta-cyclodextrin-enriched diets with either casein or soyabean concentrate as protein sources. The British Journal of Nutrition. 2000;83(4):411-420
  105. 105. Kratzer W, Kachele V, Mason RA, Muche R, Hay B, Wiesneth M, et al. Gallstone prevalence in relation to smoking, alcohol, coffee consumption, and nutrition. The Ulm gallstone study. Scandinavian Journal of Gastroenterology. 1997;32:953-958. DOI: 10.3109/00365529709011208
  106. 106. Pixley F, Wilson D, McPherson K, Mann J. Effect of vegetarianism on development of gall stones in women. British Medical Journal (Clinical Research Ed.). 1985;291:11-12. DOI: 10.1136/bmj.291.6487.11
  107. 107. Pradhan SB, Joshi MR, Vaidya A. Prevalence of different types of gallstone in the patients with cholelithiasis at Kathmandu medical college, Nepal. Kathmandu University Medical Journal (KUMJ). 2009;7(27):268-271
  108. 108. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Willett WC. Dietary predictors of symptom-associated gallstones in middle-aged women. The American Journal of Clinical Nutrition. 1990;52(5):916-922. DOI: 10.1093/ajcn/52.5.916
  109. 109. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Dietary protein and the risk of cholecystectomy in a cohort of US women: The nurses’ health study. American Journal of Epidemiology. 2004;160(1):11-18. DOI: 10.1093/aje/kwh170
  110. 110. Lander EM, Wertheim BC, Koch SM, Chen Z, Hsu CH, Thomson CA. Vegetable protein intake is associated with lower gallbladder disease risk: Findings from the Women’s Health Initiative prospective cohort. Preventive Medicine. 2016;88:20-26. DOI: 10.1016/j.ypmed.2016.03.016
  111. 111. Kameda H, Ishihara F, Shibata K, Tsukie E. Clinical and nutritional study on gallstone disease in Japan. Japanese Journal of Medicine. 1984;23(2):109-113. DOI: 10.2169/internalmedicine1962.23.109
  112. 112. Scaggion GDS, Robbi R, Susanna S. Influence of dietary fibers in the genesis of cholesterol gallstone disease. Recenti Progressi in Medicina. 1988;79(6):246-248
  113. 113. Schwesinger WH, Kurtin WE, Page CP, Stewart RM, Johnson R. Soluble dietary fiber protects against cholesterol gallstone formation. American Journal of Surgery. 1999;177(4):307-310. DOI: 10.1016/s0002-9610(99)00047-1
  114. 114. Marcus S, Heaton K. Effects of a new, concentrated wheat fibre preparation on intestinal transit, deoxycholic acid metabolism and the composition of bile. Gut. 1986;27(8):893-900. DOI: 10.1136/gut.27.8.893
  115. 115. Marcus SN, Heaton KW. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile–three inter-related factors. Gut. 1986;27(5):550-558. DOI: 10.1136/gut.27.5.550
  116. 116. Low-Beer TS. Nutrition and cholesterol gallstones. The Proceedings of the Nutrition Society. 1985;44(1):127-134. DOI: 10.1079/pns19850021
  117. 117. Tehrani AN, Saadati S, Yari Z, Salehpour A, Sadeghi A, Daftari G, et al. Dietary fiber intake and risk of gallstone: A case-control study. BMC Gastroenterology. 2023;23(1):119. DOI: 10.1186/s12876-023-02752-0
  118. 118. Waxman A. Prevention of chronic diseases: WHO global strategy on diet, physical activity and health. Food and Nutrition Bulletin. 2003;24(3):281-284. DOI: 10.1177/156482650302400306
  119. 119. Lammert F, Acalovschi M, Ercolani G, et al. EASL clinical practice guidelines on the prevention, diagnosis and treatment of gallstones. Journal of Hepatology. 2016;65(1):146-181. DOI: 10.1016/j.jhep.2016.03.005
  120. 120. Jessri M, Rashidkhani B. Dietary patterns and risk of gallbladder disease: A hospital-based case-control study in adult women. Journal of Health, Population, and Nutrition. 2015;33(1):39-49
  121. 121. Tsai CJ, Leitzmann MF, Willett WC, et al. Fruit and vegetable consumption and risk of cholecystectomy in women. The American Journal of Medicine. 2006;119(9):760-767. DOI: 10.1016/j.amjmed.2006.02.040
  122. 122. Bertola Compagnucci A, Perroud HA, Batallés SM, et al. A nested case-control study on dietary fat consumption and the risk for gallstone disease. Journal of Human Nutrition and Dietetics. 2016;29(3):338-344. DOI: 10.1111/jhn.12332
  123. 123. Figueiredo JC, Haiman C, Porcel J, et al. Sex and ethnic/racial-specific risk factors for gallbladder disease. BMC Gastroenterology. 2017;17(1):153. DOI: 10.1186/s12876-017-0678-6
  124. 124. Jayanthi V, Malathi S, Ramathilakam B, et al. Is vegetarianism a precipitating factor for gallstones in cirrhotics? Tropical Gastroenterology. 1998;19(1):21-23
  125. 125. McConnell TJ, Appleby PN, Key TJ. Vegetarian diet as a risk factor for symptomatic gallstone disease. European Journal of Clinical Nutrition. 2017;71(6):731-735. DOI: 10.1038/ejcn.2016.252
  126. 126. Rong Y, Chen L, Zhu T, et al. Egg consumption and risk of coronary heart disease and stroke: Dose-response meta-analysis of prospective cohort studies. BMJ. 2013;346:e8539. DOI: 10.1136/bmj.e8539
  127. 127. Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. Journal of Cranio-Maxillo-Facial Surgery. 2011;39(2):91-92. DOI: 10.1016/j.jcms.2010.11.001
  128. 128. Wang Y, Lu J, Wen N, Nie G, Peng D, Xiong X, et al. The role of diet and nutrition related indicators in biliary diseases: An umbrella review of systematic review and meta-analysis. Nutrition & Metabolism (London). 2022;19(1):51. DOI: 10.1186/s12986-022-00677-1
  129. 129. Zhang JW, Xiong JP, Xu WY, Sang XT, Huang HC, Bian J, et al. Fruits and vegetables consumption and the risk of gallstone diasease: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(28):e16404. DOI: 10.1097/MD.0000000000016404
  130. 130. Tsai CJ, Leitzmann MF, Willett WC, et al. Long-term intake of dietary fiber and decreased risk of cholecystectomy in women. The American Journal of Gastroenterology. 2004;99(7):1364-1370. DOI: 10.1111/j.1572-0241.2004.30153.x
  131. 131. Hunninghake DB, Miller VT, Larosa JC, et al. Hypocholesterolemic effects of a dietary fiber supplement. The American Journal of Clinical Nutrition. 1994;59(5):1050-1054. DOI: 10.1093/ajcn/59.5.1050
  132. 132. Ginter E. Cholesterol: Vitamin C controls its transformation to bile acids. Science. 1973;179(4074):702-704. DOI: 10.1126/science.179.4074.702
  133. 133. Ginter E. Chenodeoxycholic acid, gallstones and vitamin C. The New England Journal of Medicine. 1976;295(22):1260-1261. DOI: 10.1056/NEJM197611252952218
  134. 134. Jenkins SA. Hypovitaminosis C and cholelithiasis in Guinea pigs. Biochemical and Biophysical Research Communications. 1977;77(3):1030-1035. DOI: 10.1016/s0006-291x(77)80081-8
  135. 135. Jenkins SA. Biliary lipids, bile acids and gallstone formation in hypovitaminotic C Guinea-pigs. The British Journal of Nutrition. 1978;40(2):317-322. DOI: 10.1079/bjn19780128
  136. 136. Simon JA. Ascorbic acid and cholesterol gallstones. Medical Hypotheses. 1993;40(2):81-84. DOI: 10.1016/0306-9877(93)90132-a
  137. 137. Duane WC, Hutton SW. Lack of effect of experimental ascorbic acid deficiency on bile acid metabolism, sterol balance, and biliary lipid composition in man. Journal of Lipid Research. 1983;24(9):1186-1195
  138. 138. Gustafsson U, Wang FH, Axelson M, Kallner A, Sahlin S, Einarsson K. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: Prolongation of the nucleation time. European Journal of Clinical Investigation. 1997;27(5):387-391. DOI: 10.1046/j.1365-2362.1997.1240670.x
  139. 139. Simon JA, Hudes ES. Serum ascorbic acid and other correlates of gallbladder disease among US adults. American Journal of Public Health. 1998;88(8):1208-1212. DOI: 10.2105/ajph.88.8.1208
  140. 140. Simon JA, Hudes ES. Serum ascorbic acid and gallbladder disease prevalence among US adults: The third National Health and nutrition examination survey (NHANES III). Archives of Internal Medicine. 2000;160(7):931-936. DOI: 10.1001/archinte.160.7.931
  141. 141. Walcher T, Haenle MM, Kron M, Hay B, Mason RA, Walcher D, et al. Vitamin C supplement use may protect against gallstones: An observational study on a randomly selected population. BMC Gastroenterology. 2009;9:74. DOI: 10.1186/1471-230X-9-74
  142. 142. del Pozo R, Muñoz M, Dumas A, Tapia C, Muñoz K, Fuentes F, et al. Effects of vitamin C administration on cholesterol gallstone formation. Revista Médica de Chile. 2014;142(1):20-26. DOI: 10.4067/S0034-98872014000100004
  143. 143. Williams CN, Johnston JL. Prevalence of gallstones and risk factors in Caucasian women in a rural Canadian community. Canadian Medical Association Journal. 1980;122(6):664-668
  144. 144. Worthington HV, Hunt LP, McCloy RF, Maclennan I, Braganza JM. A pilot study of antioxidant intake in patients with cholesterol gallstones. Nutrition. 1997;13(2):118-127. DOI: 10.1016/s0899-9007(96)00385-1
  145. 145. Van Der Meer R, Welberg JWM, Kuipers F, Kleibeuker JH, Mulder NH, Termont D, et al. Effects of supplemental dietary calcium on the intestinal association of calcium, phosphate, and bile acids. Gastroenterology. 1990;99(6):1653-1659. DOI: 10.1016/0016-5085(90)90471-c
  146. 146. Johnston SM, Murray KP, Martin SA, Fox-Talbot K, Lipsett PA, Lillemoe KD, et al. Iron deficiency enhances cholesterol gallstone formation. Surgery. 1997;122(2):354-361; discussion 361-2. DOI: 10.1016/s0039-6060(97)90027-1
  147. 147. Humphries S, Kushner H, Falkner B. Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic black Americans. American Journal of Hypertension. 1999;12(8 Pt 1):747-756. DOI: 10.1016/s0895-7061(99)00041-2
  148. 148. Douglas BR, Jansen JBMJ, Tham RTO, Lamers CBHW. Coffee stimulation of cholecystokinin release and gallbladder contraction in humans. The American Journal of Clinical Nutrition. 1990;52(3):553-556. DOI: 10.1093/ajcn/52.3.553
  149. 149. Keiner F. The effect of coffee on gallbladder contraction. Die Medizinische Welt. 1965;34:1907-1912
  150. 150. Magnuson TH, Zarkin BA, Lillemoe KD, May CA, Bastidas JA, Pitt HA. Caffeine inhibits gallbladder absorption. Current Surgery. 1989;46(6):477-479
  151. 151. Lillemoe KD, Magnunson TH, High RC, Peoples GE, Pitt HA. Caffeine prevents cholesterol gallstone formation. Surgery. 1989;106(2):400-406 discussion 406-7
  152. 152. Rustan AC, Halvorsen B, Huggett AC, Ranheim T, Drevon CA. Effect of coffee lipids (cafestol and kahweo) on regulation of cholesterol metabolism in HepG2 cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17(10):2140-2149. DOI: 10.1161/01.atv.17.10.2140
  153. 153. Halvorsen B, Ranheim T, Nenseter MS, Huggets AC, Drevon CA. Effect of a coffee lipid (cafesol) on cholesterol metabolism in human skin fibroblast. Journal of Lipid Research. 1998;39(4):901-912
  154. 154. La Vecchia C, Negri E, D’Avanzo B, Franceschi S, Boyle P. Risk factors for gallstone disease requiring surgery. International Journal of Epidemiology. 1991;20(1):209-215. DOI: 10.1093/ije/20.1.209
  155. 155. Misciagna G, Leoci C, Guerra V, Chiloiro M, Elba S, Petruzzi J, et al. Epidemiology of cholelithiasis in southern Italy. Part II: Risk factors. European Journal of Gastroenterology & Hepatology. 1996;8(6):585-593. DOI: 10.1097/00042737-199606000-00017
  156. 156. Leitzmann MF, Willett WC, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA. 1999;281(22):2106-2112. DOI: 10.1001/jama.281.22.2106
  157. 157. Ruhl CE, Everhart JE. Association of coffee consumption with gallbladder disease. American Journal of Epidemiology. 2000;152(11):1034-1038. DOI: 10.1093/aje/152.11.1034
  158. 158. Leitzmann MF, Stampfer MJ, Willett WC, Spiegelman D, Colditz GA, Giovannucci EL. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology. 2002;123(6):1823-1830. DOI: 10.1053/gast.2002.37054
  159. 159. Jorgensen T. Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus. Gut. 1989;30(4):528-534. DOI: 10.1136/gut.30.4.528
  160. 160. Walcher T, Haenle MM, Mason RA, Koenig W, Imhof A, Kratzer W, et al. The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence. European Journal of Gastroenterology & Hepatology. 2010;22(11):1345-1351. DOI: 10.1097/MEG.0b013e32833efdb2
  161. 161. Pastides H, Tzonou A, Trichopoulos D, Katsouyanni K, Trichopoulou A, Kefalogiannis N, et al. A case-control study of the relationship between smoking, diet, and gallbladder-disease. Archives of Internal Medicine. 1990;150(7):1409-1412
  162. 162. Brown SR, Cann PA, Read NW. Effect of coffee on distal colon function. Gut. 1990;31(4):450-453. DOI: 10.1136/gut.31.4.450
  163. 163. Nordenvall C, Oskarsson V, Wolk A. Inverse association between coffee consumption and risk of cholecystectomy in women but not in men. Clinical Gastroenterology and Hepatology. 2015;13(6):1096-1102.e1. DOI: 10.1016/j.cgh.2014.09.029
  164. 164. Andreotti G, Liu E, Gao YT, et al. Medical history and the risk of biliary tract cancers in Shanghai, China: Implications for a role of inflammation. Cancer Causes & Control. 2011;22(9):1289-1296. DOI: 10.1007/s10552-011-9802-z
  165. 165. Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis. British Journal of Cancer. 2015;112(3):580-593. DOI: 10.1038/bjc.2014.579
  166. 166. Ahrens W, Timmer A, Vyberg M, et al. Risk factors for extrahepatic biliary tract carcinoma in men: Medical conditions and lifestyle: Results from a European multicentre case-control study. European Journal of Gastroenterology & Hepatology. 2007;19(8):623-630. DOI: 10.1097/01.meg.0000243876.79325.a1
  167. 167. Shabanzadeh DM, Novovic S. Alcohol, smoking and benign hepato-biliary disease. Best Practice & Research. Clinical Gastroenterology. 2017;31(5):519-527. DOI: 10.1016/j.bpg.2017.09.005
  168. 168. Wang J, Duan X, Li B, Jiang X. Alcohol consumption and risk of gallstone disease: A meta-analysis. European Journal of Gastroenterology & Hepatology. 2017;29(4):e19-e28. DOI: 10.1097/MEG.0000000000000803
  169. 169. Cha BH, Jang M-J, Lee SH. Alcohol consumption can reduce the risk of gallstone disease: A systematic review with a dose-response meta-analysis of case-control and cohort studies. Gut Liver. 2019;13(1):114-131. DOI: 10.5009/gnl18278
  170. 170. Johansson K, Sundstrom J, Marcus C, Hemmingsson E, Neovius M. Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study. International Journal of Obesity. 2014;38:279-284. DOI: 10.1038/ijo.2013.83
  171. 171. Banim PJ, Luben RN, Bulluck H, Sharp SJ, Wareham NJ, Khaw KT, et al. The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk). European Journal of Gastroenterology & Hepatology. 2011;23(8):733-740. DOI: 10.1097/MEG.0b013e3283477cc9
  172. 172. Basso L, McCollum PT, Darling MR, Tocchi A, Tanner WA. A descriptive study of pregnant women with gallstones. Relation to dietary and social habits, education, physical activity, height, and weight. European Journal of Epidemiology. 1992;8(5):629-633. DOI: 10.1007/BF00145375
  173. 173. Hannuksela ML, Rantala M, Kesaniemi YA, Savolainen MJ. Ethanol-induced redistribution of cholesteryl ester transfer protein (CETP) between lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16(2):213-221. DOI: 10.1161/01.atv.16.2.213
  174. 174. Thornton J, Symes C, Heaton K. Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol. Lancet. 1983;2(8354):819-822. DOI: 10.1016/s0140-6736(83)90738-9
  175. 175. Thornton JR, Heaton KW, Macfarlane DG. A relation between high-density-lipoprotein cholesterol and bile cholesterol saturation. British Medical Journal (Clinical Research Ed.). 1981;283(6303):1352-1354. DOI: 10.1136/bmj.283.6303.1352
  176. 176. Saluja AK, Bhagat L. Pathophysiology of alcohol-induced pancreatic injury. Pancreas. 2003;27(4):327-331. DOI: 10.1097/00006676-200311000-00010
  177. 177. Probert C, Emmett P, Heaton K. Some determinants of whole-gut transit time: A population-based study. QJM. 1995;88(5):311-315
  178. 178. Rebholz C, Krawczyk M, Lammert F. Genetics of gallstone disease. European Journal of Clinical Investigation. 2018;48(7):e12935. DOI: 10.1111/eci.12935
  179. 179. Arrese M, Cortés V, Barrera F, Nervi F. Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: New insights on a complex relationship. Current Opinion in Gastroenterology. 2018;34(2):90-96. DOI: 10.1097/MOG.0000000000000416
  180. 180. Yuan S, Giovannucci EL, Larsson SC. Gallstone disease, diabetes, calcium, triglycerides, smoking and alcohol consumption and pancreatitis risk: Mendelian randomization study. NPJ Genomic Medicine. 2021;6(1):27. DOI: 10.1038/s41525-021-00189-6
  181. 181. Kono S, Eguchi H, Honjo S, Todoroki I, Oda T, Shinchi K, et al. Cigarette smoking, alcohol use, and gallstone risk in Japanese men. Digestion. 2002;65(3):177-183. DOI: 10.1159/000064938
  182. 182. Rhodes M, Venables C. Symptomatic gallstones-a disease of non-smokers? Digestion. 1991;49(4):221-226. DOI: 10.1159/000200725
  183. 183. Tsaroucha AK, Chatzaki E, Lambropoulou M, Despoudi K, Laftsidis P, Charsou C, et al. Megalin and cubilin in the human gallbladder epithelium. Clinical and Experimental Medicine. 2008;8(3):165-170. DOI: 10.1007/s10238-008-0174-y
  184. 184. Erranz B, Miquel JF, Argraves WS, Barth JL, Pimentel F, Marzolo MP. Megalin and cubilin expression in gallbladder epithelium and regulation by bile acids. Journal of Lipid Research. 2004;45(12):2185-2198. DOI: 10.1194/jlr.M400235-JLR200
  185. 185. Marzolo MP, Farfán P. New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biological Research. 2011;44(1):89-105. DOI: 10.4067/S0716-97602011000100012
  186. 186. Stofan M, Guo GL. Bile acids and FXR: Novel targets for liver diseases. Frontiers in Medicine (Lausanne). 2020;7:544. DOI: 10.3389/fmed.2020.00544
  187. 187. Gao Q , Bi P, Mi Q , Guan Y, Jiang J, Li X, et al. Effect of nicotine on cholesterol gallstone formation in C57BL/6J mice fed on a lithogenic diet. Experimental and Therapeutic Medicine. 2023;25(2):84. DOI: 10.3892/etm.2023.11783
  188. 188. Lamberts MP, Lugtenberg M, Rovers MM, et al. Persistent and de novo symptoms after cholecystectomy: A systematic review of cholecystectomy effectiveness. Surgical Endoscopy. 2013;27(3):709-718. DOI: 10.1007/s00464-012-2516-9
  189. 189. Wennmacker S, Lamberts M, Gerritsen J, et al. Consistency of patient-reported outcomes after cholecystectomy and their implications on current surgical practice: A prospective multicenter cohort study. Surgical Endoscopy. 2017;31(1):215-224. DOI: 10.1007/s00464-016-4959-x
  190. 190. Latenstein CSS, Wennmacker SZ, de Jong JJ, van Laarhoven CJHM, Drenth JPH, de Reuver PR. Etiologies of long-term Postcholecystectomy symptoms: A systematic review. Gastroenterology Research and Practice. 2019;2019:4278373. DOI: 10.1155/2019/4278373
  191. 191. Malagelada JR, Go VL, Summerskill WH, Gamble WS. Bile acid secretion and biliary bile acid composition altered by cholecystectomy. The American Journal of Digestive Diseases. 1973;18:455-459. DOI: 10.1007/BF01076595
  192. 192. Fort JM, Azpiroz F, Casellas F, Andreu J, Malagelada JR. Bowel habit after cholecystectomy: Physiological changes and clinical implications. Gastroenterology. 1996;111(3):617-622. DOI: 10.1053/gast.1996.v111.pm8780565
  193. 193. Sciarretta G, Furno A, Mazzoni M, Malaguti P. Post-cholecystectomy diarrhea: Evidence of bile acid malabsorption assessed by SeHCAT test. The American Journal of Gastroenterology. 1992;87(12):1852-1854
  194. 194. Yueh TP, Chen FY, Lin TE, Chuang MT. Diarrhea after laparoscopic cholecystectomy: Associated factors and predictors. Asian Journal of Surgery. 2014;37(4):171-177. DOI: 10.1016/j.asjsur.2014.01.008
  195. 195. Fisher M, Spilias DC, Tong LK. Diarrhoea after laparoscopic cholecystectomy: Incidence and main determinants. ANZ Journal of Surgery. 2008;78(6):482-486. DOI: 10.1111/j.1445-2197.2008.04539.x
  196. 196. Johnson AG. Gallstones and flatulent dyspepsia: Cause or coincidence? Postgraduate Medical Journal. 1971;47(554):767-772. DOI: 10.1136/pgmj.47.554.767
  197. 197. Altomare DF, Rotelli MT, Palasciano N. Diet after cholecystectomy. Current Medicinal Chemistry. 2019;26(19):3662-3665. DOI: 10.2174/0929867324666170518100053
  198. 198. Shin Y, Choi D, Lee KG, Choi HS, Park Y. Association between dietary intake and postlaparoscopic cholecystectomic symptoms in patients with gallbladder disease. The Korean Journal of Internal Medicine. 2018;33(4):829-836. DOI: 10.3904/kjim.2016.223
  199. 199. Ribas Blasco Y, Pérez Muñante M, Gómez-Fernández L, Jovell-Fernández E, Oms Bernad LM. Low-fat diet after cholecystectomy: Should it be systematically recommended? Cirugía Española (English Edition). 2020;98(1):36-42. English, Spanish. DOI: 10.1016/j.ciresp.2019.05.009
  200. 200. Marcason W. What medical nutrition therapy guideline is recommended post-cholecystectomy? Journal of the Academy of Nutrition and Dietetics. 2014;114(7):1136. DOI: 10.1016/j.jand.2014.05.009
  201. 201. Burn-Murdoch RA, Fisher MA, Hunt JN. The slowing of gastric emptying by proteins in test meals. The Journal of Physiology. 1978;274:477-485. DOI: 10.1113/jphysiol.1978.sp012161
  202. 202. Uchida K, Nomura Y, Kadowaki M, Takeuchi N, Yamamura Y. Effect of dietary cholesterol on cholesterol and bile acid metabolism in rats. Japanese Journal of Pharmacology. 1977;27(2):193-204. DOI: 10.1254/jjp.27.193
  203. 203. Hutcheon DF, Bayless TM, Gadacz TR. Postcholecystectomy diarrhea. Journal of the American Medical Association. 1979;241(8):823-824
  204. 204. Adiotomre J, Eastwood MA, Edwards CA, Brydon WG. Dietary fiber: in vitro methods that anticipate nutrition and metabolic activity in humans. The American Journal of Clinical Nutrition. 1990;52(1):128-134. DOI: 10.1093/ajcn/52.1.128
  205. 205. Shim P, Choi D, Park Y. Association of blood fatty acid composition and dietary pattern with the risk of non-alcoholic fatty liver disease in patients who underwent cholecystectomy. Annals of Nutrition & Metabolism. 2017;70(4):303-311. DOI: 10.1159/000475605

Written By

Reginald del Pozo

Submitted: 29 May 2023 Reviewed: 06 June 2023 Published: 06 September 2023